Slamming the brakes on the malaria life cycle

Scientists have discovered a new target in their fight against the devastating global disease 'malaria' thanks to the discovery of a new protein involved in the parasite's life cycle.

The research has uncovered a vital player in the sexual phase of the malaria parasite's reproduction which could prove an effective target for new treatments to stop the disease in its tracks.

The scientists from The University of Nottingham's School of Biology, with collaborators from the Universities of Leicester, Oxford, Imperial College London and Leiden in the Netherlands, have just published the results of their work in the journal PLoS Pathogens.

Malaria is a devastating global disease with several hundred million clinical cases and just under a million people die from it every year. The disease is caused by an infection of the with a tiny parasite called a , of which there are four important species. These organisms are carried from person to person by the Anopheles mosquito. When it bites an infected person, the mosquito sucks up blood containing the parasite, which may then be passed on to the mosquito's next victim.

Dr David Guttery, lead scientist of the paper and part of Dr Tewari's group from the University of Nottingham's Centre for Genetics and Genomics in the School of Biology said:

"The malaria parasite is a complex organism and to understand how it multiplies is crucial to stopping its transmission. Our study has identified a cell-division cycle gene in the malaria parasite and its role in the development of male sex cells and is hence a good candidate for putting the brakes on its development. We have shown that by deleting this gene, male gametes cannot form and burst out of their (a process called exflagellation). Blocking the formation of these cells can be an important strategy in the prevention of from mosquito to mammalian hosts".

The protein that has been identified is called CDC20 and plays a part in the cell division cycle of the malaria parasite Plasmodium berghei which infects mice and rats. This gene has been shown to have an important role in cell division in many organisms, but up to now nothing has been known about its function in the malaria parasite. The new study provides the first description of the role of CDC20 in Plasmodium cell division and in the development of the malaria parasite's male (microgametes), which are essential for parasite transmission between humans and the mosquito carrier. The scientists have discovered that the absence of this gene stops the male sex cell from bursting out of its host cell and fertilising a female cell as they are arrested in their .

The sexual stage of the malaria parasite's life-cycle occurs within the mosquito after it has fed on malaria-infected blood. This activates the parasite's sexual phase and during this period, the male sex cell precursor (microgametocyte) rapidly replicates it DNA and produces 8 male sex (gametes). These gametes then burst out of the microgametocyte in a process called exflagellation and seek out a female sex cell to fertilise. By blocking the process of exflagellation, the team have identified a way of slamming the brakes on malaria transmission.

The team of researchers were from the Centre of Genetics and Genomics at The University of Nottingham, the University of Oxford, Imperial College London, Leiden University, the University of Leicester and the MRC National Institute for Medical Research funded by the MRC, Wellcome Trust, and EviMalar.

The group at Nottingham has previously uncovered other major players in the of the . More details on these can be found in earlier media releases 'Stopping the spread of malaria' and 'Malaria research begins to bite'.

More information: PLoS Pathogens, DOI:10.1371/journal.ppat.1002554

Related Stories

Malaria research bites back

Oct 21, 2010

Scientists at The University of Nottingham and the Wellcome Trust Sanger Institute near Cambridge have pin-pointed the 72 molecular switches that control the three key stages in the life cycle of the malaria ...

Recommended for you

Researcher studies protein's link to heart disease

Jun 18, 2013

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

The rhythm of everything

Jun 18, 2013

Dawn triggers basic biological changes in the waking human body. As the sun rises, so does heart rate, blood pressure and body temperature. The liver, the kidneys and many natural processes also begin shifting ...

User comments

More news stories

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

Renewed hope in a once-abandoned cancer drug class

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

Protalix signs supply deal with Brazilian govt

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...